{"transactions":[{"id":3408314,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":154827,"kind":"organization","name":"H.I.G. Bio-Exagen, L.P.","position":1,"cik":"0001788396","reported_name":"H.I.G. Bio-Exagen, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":128784,"kind":"organization","name":"H.I.G.-GPII, Inc.","position":2,"cik":"0001788482","reported_name":"H.I.G.-GPII, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90453,"kind":"person","name":"TAMER ANTHONY","position":3,"cik":"0001050045","reported_name":"TAMER ANTHONY","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90452,"kind":"person","name":"MNAYMNEH SAMI","position":4,"cik":"0001050046","reported_name":"MNAYMNEH SAMI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series H Redeemable Convertible Preferred Stock","published_at":"2019-09-23T21:43:23.000Z","date":"2019-09-23","kind":"exercise","acquired":false,"shares":233446519,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series H Redeemable Convertible Preferred Stock (\"Series H\") is convertible into the Issuer's Common Stock on a 183.635-for-one basis at the holder's election and has no expiration date. The Series H automatically converted into Common Stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series H Redeemable Convertible Preferred Stock (\"Series H\") is convertible into the Issuer's Common Stock on a 183.635-for-one basis at the holder's election and has no expiration date. The Series H automatically converted into Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series H Redeemable Convertible Preferred Stock (\"Series H\") is convertible into the Issuer's Common Stock on a 183.635-for-one basis at the holder's election and has no expiration date. The Series H automatically converted into Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series H Redeemable Convertible Preferred Stock (\"Series H\") is convertible into the Issuer's Common Stock on a 183.635-for-one basis at the holder's election and has no expiration date. The Series H automatically converted into Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares reported on this form are held of record by H.I.G. Bio-Exagen, L.P. (\"H.I.G.\"). H.I.G.-GPII, Inc. (\"H.I.G. GP\") is the general partner of H.I.G. and has sole voting and investment control over the shares owned by H.I.G. Anthony Tamer and Sami Mnaymneh are the sole shareholders of H.I.G. GP and may be deemed to share beneficial ownership of the shares held by H.I.G. Bio-Exagen, L.P. Each of Mr. Tamer and Mr. Mnaymneh disclaims beneficial ownership of the shares reported herein except to the extent of their pecuniary interest, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1271252},"source":{"system":"sec-edgar","filing":"0000899243-19-024078","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1050045/000089924319024078/doc4.xml","form_type":"4"}},{"id":3408313,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":154827,"kind":"organization","name":"H.I.G. Bio-Exagen, L.P.","position":1,"cik":"0001788396","reported_name":"H.I.G. Bio-Exagen, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":128784,"kind":"organization","name":"H.I.G.-GPII, Inc.","position":2,"cik":"0001788482","reported_name":"H.I.G.-GPII, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90453,"kind":"person","name":"TAMER ANTHONY","position":3,"cik":"0001050045","reported_name":"TAMER ANTHONY","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90452,"kind":"person","name":"MNAYMNEH SAMI","position":4,"cik":"0001050046","reported_name":"MNAYMNEH SAMI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-23T21:43:23.000Z","date":"2019-09-23","kind":"purchase","acquired":true,"shares":425000,"price":14,"value":5950000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares reported on this form are held of record by H.I.G. Bio-Exagen, L.P. (\"H.I.G.\"). H.I.G.-GPII, Inc. (\"H.I.G. GP\") is the general partner of H.I.G. and has sole voting and investment control over the shares owned by H.I.G. Anthony Tamer and Sami Mnaymneh are the sole shareholders of H.I.G. GP and may be deemed to share beneficial ownership of the shares held by H.I.G. Bio-Exagen, L.P. Each of Mr. Tamer and Mr. Mnaymneh disclaims beneficial ownership of the shares reported herein except to the extent of their pecuniary interest, if any."}],"balance_after":1696252,"source":{"system":"sec-edgar","filing":"0000899243-19-024078","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1050045/000089924319024078/doc4.xml","form_type":"4"}},{"id":3408312,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":154827,"kind":"organization","name":"H.I.G. Bio-Exagen, L.P.","position":1,"cik":"0001788396","reported_name":"H.I.G. Bio-Exagen, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":128784,"kind":"organization","name":"H.I.G.-GPII, Inc.","position":2,"cik":"0001788482","reported_name":"H.I.G.-GPII, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90453,"kind":"person","name":"TAMER ANTHONY","position":3,"cik":"0001050045","reported_name":"TAMER ANTHONY","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90452,"kind":"person","name":"MNAYMNEH SAMI","position":4,"cik":"0001050046","reported_name":"MNAYMNEH SAMI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-23T21:43:23.000Z","date":"2019-09-23","kind":"exercise","acquired":true,"shares":1271252,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares reported on this form are held of record by H.I.G. Bio-Exagen, L.P. (\"H.I.G.\"). H.I.G.-GPII, Inc. (\"H.I.G. GP\") is the general partner of H.I.G. and has sole voting and investment control over the shares owned by H.I.G. Anthony Tamer and Sami Mnaymneh are the sole shareholders of H.I.G. GP and may be deemed to share beneficial ownership of the shares held by H.I.G. Bio-Exagen, L.P. Each of Mr. Tamer and Mr. Mnaymneh disclaims beneficial ownership of the shares reported herein except to the extent of their pecuniary interest, if any."}],"balance_after":1271252,"source":{"system":"sec-edgar","filing":"0000899243-19-024078","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1050045/000089924319024078/doc4.xml","form_type":"4"}}]}